Medicine Manufacturer Vietnam | Vinphaco Speaker Tour Nghe An 2026 — Obstetric Safety Across North-Central Vietnam

Medicine Manufacturer Vietnam — Vinphaco Speaker Tour Extends Obstetric Safety Program to North-Central Vietnam 

On September 25, 2026, Vinphaco’s Speaker Tour reached Nghe An Province at Nghe An Obstetrics and Paediatrics Hospital — convening nearly 120 healthcare professionals from both Nghe An and Ha Tinh provinces with three specialist faculty drawn from Vietnam’s foremost obstetric anaesthesia and maternal medicine institutions. The session focused on safe clinical practice in obstetrics, covering regional anaesthesia for labour pain management and postpartum haemorrhage intervention protocols. For a medicine manufacturer Vietnam supplying anaesthetic agents, uterotonic formulations, and critical care active ingredients across domestic hospital channels and 24 international export markets, this clinical education investment is direct engagement with the specialist community whose practice standards define how those products are used. Explore Vinphaco’s Vietnamese operations at vinphaco.net 

1. Two-Province Reach — A First for the Vinphaco Speaker Tour Series 

The Nghe An session marks the first time in the 2026 Vinphaco Speaker Tour series that a single event has drawn healthcare professionals from two provinces simultaneously — Nghe An and Ha Tinh. This dual-province attendance reflects the geographic reach of Nghe An Obstetrics and Paediatrics Hospital as a regional referral centre for North-Central Vietnam, and the appetite for specialist clinical education in a region where the ratio of national-level specialist faculty to practicing clinicians is lower than in major urban medical centres. 

For international pharmaceutical partners, this geographic expansion within the Speaker Tour series signals that Vinphaco’s domestic clinical engagement is not concentrated in Vietnam’s largest markets — it is systematically reaching the full clinical geography of the country, including provinces where specialist access is most limited and where quality pharmaceutical supply has the most direct impact on clinical outcomes. 

2. Faculty — National Obstetric Anaesthesia Leadership and Academic Maternal Medicine Expertise 

Three specialists delivered the Nghe An scientific program, representing complementary dimensions of the session’s dual clinical focus. 

Associate Professor Nguyen Duc Lam, PhD — Head, Voluntary Anaesthesia Department, Hanoi Obstetrics Hospital; Senior Lecturer, Department of Anaesthesiology, Hanoi Medical University; Standing Vice President, Vietnam Obstetric Anaesthesia Society. As the standing vice president of Vietnam’s national obstetric anaesthesia professional body, Assoc. Prof. Nguyen Duc Lam carries the highest institutional authority in the country on regional anaesthesia standards for obstetric settings — bringing to Nghe An the most current national consensus on safe and effective labour analgesia protocols. 

Associate Professor Le Thi Anh Dao, PhD — Head, Gynaecological Surgery Department A5, Hanoi Obstetrics Hospital; Senior Lecturer, Department of Obstetrics and Gynaecology, Hanoi Medical University. A senior obstetrician with combined clinical and academic leadership across Vietnam’s premier obstetric institution and its primary medical university, Assoc. Prof. Le Thi Anh Dao delivered the maternal medicine perspective on postpartum haemorrhage recognition and management — directly relevant to the high-stakes emergency context where treatment protocol adherence most directly determines maternal survival outcomes. 

Dr. Tran Minh Long — Head, Anaesthesiology Department, Nghe An Obstetrics and Paediatrics Hospital. As the host institution’s own anaesthesia department head, Dr. Tran Minh Long provided the operational bridge between national clinical standards and the specific resource environment and patient population characteristics of North-Central Vietnam’s provincial obstetric practice. 

3. Obstetric Safety — Clinical Relevance Across Vinphaco’s Export Markets 

The clinical focus of the Nghe An session — postpartum haemorrhage management and regional anaesthesia safety — maps directly onto maternal health priorities across Vinphaco’s international export network. Postpartum haemorrhage remains the leading cause of preventable maternal death globally, with disproportionate burden in the low-to-middle income country markets that constitute Vinphaco’s primary export geography across Sub-Saharan Africa, Central Asia, and Pacific Oceania. 

For international buyers, a medicine manufacturer Vietnam whose domestic clinical education program consistently engages with the obstetric specialists managing these conditions — across multiple provinces, with national faculty, and building on previous sessions rather than repeating them — is one whose understanding of maternal medicine clinical requirements informs its manufacturing priorities in ways that purely production-focused manufacturers cannot match. 

4. 1,470+ Clinicians — The 2026 Engagement Record Continues to Build 

The Nghe An session extends the Vinphaco Speaker Tour and clinical engagement cumulative reach to over 1,470 healthcare professionals across Vietnam in 2026 — spanning respiratory medicine, hospital infection control, clinical pharmacy, pediatric cardiology, obstetric anaesthesia, and maternal medicine, across Bac Ninh, Can Tho, Phu Yen, Dong Thap, Quang Nam, Ninh Binh, and now Nghe An and Ha Tinh simultaneously. 

For international pharmaceutical supply partners, this record represents the most comprehensive domestic clinical validation program of any medicine manufacturer Vietnam operating at Vinphaco’s scale — and the strongest available evidence that Vinphaco’s quality standards are continuously tested and trusted by Vietnam’s specialist clinical community. 

To discuss pharmaceutical contract manufacturing, obstetric and anaesthetic active ingredient supply, or international distribution partnerships: vinphaco.net